[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364474-105":59,"doc-detail-364474-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prospective-validation-study-a-non-invasive-circulating-tumor-dna-based-assay-for-simultaneous-early-detection-of-multiple-cancers-in-asymptomatic-adults","Prospective validation study - A non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults","","Non-invasive multi-cancer early detection (MCED) tests have shown promise, but clinical utility across diverse populations remains insufficiently validated. This prospective multicenter study validates SPOT-MAS, a multimodal circulating tumor DNA (ctDNA)-based MCED test combining DNA methylation and size analysis, for early detection in asymptomatic adults. A total of 9057 individuals aged 40 years or older in Vietnam were followed for 12 months across 75 hospitals and one research institute. Among 9024 eligible participants, ctDNA positives yielded a positive predictive value and tissue-of-origin accuracy, while ctDNA negatives showed a very high negative predictive value. The assay achieved overall sensitivity and specificity for multiple cancer types, including cancers without standard-of-care screening options, supporting potential integration into national screening programs, especially where screening initiatives are limited.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prospective-validation-study-a-non-invasive-circulating-tumor-dna-based-assay-for-simultaneous-early-detection-of-multiple-cancers-in-asymptomatic-adults/364474/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prospective-validation-study-a-non-invasive-circulating-tumor-dna-based-assay-for-simultaneous-early-detection-of-multiple-cancers-in-asymptomatic-adults/364474.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SPOT-MAS and what does it target?","Question",{"text":112,"@type":113},"SPOT-MAS is a multimodal, non-invasive ctDNA-based MCED test. It targets simultaneous early detection of multiple cancers in asymptomatic adults using DNA methylation and size information.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the prospective validation study conducted?",{"text":117,"@type":113},"The study used a multicenter prospective design (K-DETEK, NCT05227261) enrolling 9057 asymptomatic individuals aged 40+ across 75 hospitals and one research institute in Vietnam. Participants were followed for 12 months.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance did the test show?",{"text":121,"@type":113},"Among eligible participants, ctDNA positives were evaluated against malignant lesions confirmed by standard-of-care imaging and biopsy, with reported positive predictive value and tissue-of-origin accuracy. ctDNA negatives showed a very high negative predictive value, and the overall sensitivity and specificity were reported for detecting various cancer types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364474,1790488131,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Nguyen et al. BMC Medicine (2025) 23:90 [https://doi.org/10.1186/s12916-025-03929-y](https://doi.org/10.1186/s12916-025-03929-y)  \nBMC Medicine  \n RESEARCH Open Access  \nProspective validation study: a non-  invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults  \nLuu Hong Dang Nguyen1†, Thi Hue Hanh Nguyen1†, Van Hoi Le2, Vinh Quang Bui3, Lan Hieu Nguyen4, Nhu Hiep Pham5, Thanh Hai Phan6, HuuThinh Nguyen7, Van Song Tran8, Chi Viet Bui9, Van Kha Vo10, Pham Thanh Nhan Nguyen11, Ha Huu Phuoc Dang12, Van Dung Pham 13, Van Thinh Cao14, Ngoc Minh Phan 1, Ba Linh Tieu1, Giang Thi Huong Nguyen1, Dac Ho Vo1, Trung HieuTran1, Thanh Dat Nguyen1,  \nVan Thien Chi Nguyen1, Trong Hieu Nguyen 1, Vu Uyen Tran1, Minh Phong Le 1, Thi Minh ThuTran1,  \nMinh Nguyen Nguyen1, Thi TuongViVan1, Anh Nhu Nguyen 1, Thi Thanh Nguyen 1, Nhu Nhat Tan Doan 1, Hoang Tan Nguyen 1, Phuoc Loc Doan1, Le Anh Khoa Huynh 1, Tien Anh Nguyen 1, HuuTam Phuc Nguyen1, Y.-Thanh Lu 1, Chi Thuy Tien Cao1, Van Tung Nguyen2, Thi Le Quyen Le3, Thi Lan-Anh Luong4,  \nThi Kim Phuong Doan4, Thi Trang Dao4, Canh Duy Phan5, Thanh Xuan Nguyen5, Nguyen Tuong Pham5, Bao Toan Nguyen6, ThiThuThuy Pham6, Huu Linh Le6, Cong Thanh Truong6, Thanh Xuan Jasmine6,  \nMinh Chi Le7, Van Bau Phan8, Quang Binh Truong7, Thi Huong Ly Tran10, Minh Thien Huynh10, Tu Quy Tran11, SiTuan Nguyen13, VuTran13, Van KhanhTran14, Huu Nguyen Nguyen1,15, Duy Sinh Nguyen 1,15, ThiVan Phan 1, Thi Thanh-Thuy Do1, Dinh Kiet Truong1, Hung Sang Tang1, Hoa Giang1,15, Hoai-Nghia Nguyen 1,15,  \nMinh-Duy Phan 1,15* and Le SonTran1,15*  \nAbstract  \nBackground Non-invasive multi-cancer early detection (MCED) tests have shown promise in enhancing early cancer detection. However, their clinical utility across diverse populations remains underexplored, limiting their routine implementation. This study aims to validate the clinical utility of a multimodal non-invasive circulating tumor DNA (ctDNA)-based MCED test, SPOT-MAS (Screening for the Presence Of Tumor by DNA Methylation And Size) .  \nMethods We conducted a multicenter prospective study, K-DETEK ([ClinicalTrials.gov](ClinicalTrials.gov) identifier: NCT05227261), involving 9057 asymptomatic individuals aged 40 years or older across 75 major hospitals and one research institute in Vietnam. Participants were followed for 12 months.  \n†Luu Hong Dang Nguyen and Thi Hue Hanh Nguyen contributed equally to this work.  \n*Correspondence: Minh-Duy Phan [pmduy@yahoo.com](pmduy@yahoo.com)[ ](pmduy@yahoo.com)Le SonTran [leson1808@gmail.com](leson1808@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nNguyen et al. BMC Medicine (2025) 23:90 Page 2 of 14  \nResults Of the 9024 eligible participants, 43 (0 .48%) tested positive for ctDNA. Among these, 17 were c","cbCaibk1KfheFSvk","https://ap.wps.com/l/cbCaibk1KfheFSvk","pdf",2193726,14,"English","# Background\n# Methods\n## Study design and participants\n# Results\n# Conclusions\n# Trial registration\n# Keywords","[{\"question\":\"What is SPOT-MAS and what does it target?\",\"answer\":\"SPOT-MAS is a multimodal, non-invasive ctDNA-based MCED test. It targets simultaneous early detection of multiple cancers in asymptomatic adults using DNA methylation and size information.\"},{\"question\":\"How was the prospective validation study conducted?\",\"answer\":\"The study used a multicenter prospective design (K-DETEK, NCT05227261) enrolling 9057 asymptomatic individuals aged 40+ across 75 hospitals and one research institute in Vietnam. Participants were followed for 12 months.\"},{\"question\":\"What diagnostic performance did the test show?\",\"answer\":\"Among eligible participants, ctDNA positives were evaluated against malignant lesions confirmed by standard-of-care imaging and biopsy, with reported positive predictive value and tissue-of-origin accuracy. ctDNA negatives showed a very high negative predictive value, and the overall sensitivity and specificity were reported for detecting various cancer types.\"}]","Prospective validation study - A non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults | PDF",1790157719,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6cf8c8828d654b04b7e968c9c6bf7c1.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9693e1437051647860588ec3d2e747ee.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/735d7baa925ebefd4aa0c88cd07419c7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f47a3489ab7ad6d947dbd5744cad572.webp",980,1301]